Korean Medication Algorithm for Bipolar Disorder 2014: Medical Comorbidity.
- Author:
Moon Doo KIM
1
;
Jung Goo LEE
;
Bo Hyun YOON
;
Young Eun JUNG
;
Jong Hyun JEONG
;
Inki SOHN
;
Se Hoon SHIM
;
Young Sup WOO
;
Duk In JON
;
Jeong Seok SEO
;
Young Chul SHIN
;
Kyung Joon MIN
;
Won Myong BAHK
Author Information
1. Department of Psychiatry, Jeju National University Hospital, Jeju, Korea.
- Publication Type:Original Article
- Keywords:
Bipolar disorder;
Medical comorbidity;
Pharmacotherapy;
Algorithm
- MeSH:
Advisory Committees;
Bipolar Disorder*;
Comorbidity*;
Consensus;
Drug Therapy;
Expert Testimony;
Humans;
Psychiatry;
Surveys and Questionnaires;
Valproic Acid;
Aripiprazole;
Quetiapine Fumarate
- From:Korean Journal of Psychopharmacology
2014;25(4):155-160
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The third revision of Korean Medication Algorithm Project for Bipolar Disorder was performed in 2014 in order to provide more proper guideline for clinicians. In this study, we undertook a survey of expert opinion to help clinical decisions in medical comorbidities. METHODS: The questionnaire to survey the expert opinion of medication for bipolar disorder was completed by the review committee consisting of 64 experienced psychiatrists. This survey was composed of 56 main questionnaires of which the contents covered from overall treatment strategies to treatment strategies under the specific situations. The executive committee analyzed the results and discussed the final production of algorithm. RESULTS: In bipolar patients with cardiovascular, diabetic, or hepatic comorbidities, aripiprazole was first-line treatment strategy. In case of renal comorbidity accompanying bipolar disorder, aripiprazole, valproate, and quetiapine were preferred. Valproate was recommended as the first-line strategy in case of bipolar disorder with cerebrovascular diseases. CONCLUSION: This study provided information about the consensus among experts in regard to treatment strategies for bipolar disorder in the medically ill.
